Meet David Black
Patent Profile Analytics and Engineers
Are BioSimilars Being Approved in the US?
Patent Owner Rights
Patent Analytics and Competition
Do Narrow Patents Add Value to a Portfolio?
Value Management Lifecycle
Forward Citation Landscape
Inventors and Patent Analytics
Factors That Cause a Patent to Decline in Value
Trade Names vs Trademarks
Low Risk Joint Ventures
Patent Examination Process
Rewards of the Practice
Consequences of a Poorly Drafted Patent
Contractual Intellectual Property Rights
Golden Rule of Auditing a Patent Portfolio
Value Management and Risk Management
Covered Business Method Review
Effective Stay Strategy
Cost/Value Curve of a High Level Patent
Common Law Trademark Rights
Joint Ventures and Dispute Resolution
Schwegman Lundberg & Woessner & Post Grant Trial Practice
What Makes Schwegman, Lundberg & Woessner Different?
Wasting Money on Low-Value Patents
Trademarks and Brand Value
How to Navigate BioSimilar Challenges
What is a Patent?
Third Party Confidentiality
Auction Audit Sheet - Key Issues to Address
Post-Grant Options and Grounds of Challenge
Approvals of BioSimilars in Europe
Standard for Getting a Patent
What is a BioSimilar Product Under US Law?
Types of Inventions That Are Patentable
"Whats" - Audit Action Sheet
Importance of Post-Grant Proceedings
Picking a Domain Name
Reasons to Consider Joint Ventures
Patent Profile Analytics and Researchers
Tracking Work History
Litigation and BioSimilar Patenting
Who Determines Substitution Factors?
Process for Registering a Trademark in the United States
Cost of Registering a Trademark
Prior Art Challenge
How is Schwegman Lundberg & Woessner Different?
Different Parts of a Patent Document
Raising Good Prosecution Visibility
What Should a Company Patent?
Determining Likelihood of Confusion
PTAB Timing Trial Dynamics
How to Remedy Unwanted Disclosure of Confidential Information
Patent Status Updates
Claim Abstraction Theory
"Whens" - Audit Action Sheet
Considerations Before Hiring IP Council
Researching Competitors' IP
Should IP be Part of Our Business Plan?
How to Fix the Knowledge Gap
Post-Grant Options and Estoppel
Helping In-House Council
Limited Valuable Patents in Technology Area
BioSimilar Patenting Litigation Involving Large Amounts of Money
Types of Intellectual Property Protection
Ideal Patent Strategy
What Doesn't a Patent Provide?
Proper Way to Use a Trademark
Qualifying for a Patent
Refused Trademark Recourse
What is a Patent Portfolio?
When to Do a Freedom to Operate
Provisional vs Non-Provisional Patent
Using Product Association with IP Assets
Improperly Marked Product
The Different Types of Marks
Open Source Software
Mitigating Risks of Past Damages
Why Is Executing an NDA Not Enough?
Trade Name Protection and Trademark Protection
Meet Mark Stignani
What Do I Give up in Getting My Patent?
Cited Art Landscape
Forms of Confidential Information
The Five Components of an Open Source Software Policy
Secondary Meaning of a Trademark
Purposes of a Trademark
5 Year View Point
Equal Value Patents
Hiring Patent Council
Outside of Law
What is a Trademark?
Most Common Client Question
How Should IP be Considered for Acquisition?
NDAs and Computer Codes
How Much Does it Cost to Get a Patent?
NDAs and Customers
First Item on IP To-Do List
Patent Citation Ranking
Intellectual Property Protection
Naming Problems with BioSimilars
Advantages of Registering a Trademark
Post-Grant Options and Cost
Patents and Other Forms of Intellectual Property Protection
Downside of Static Budget Allocation for Patents
How Do Patent Portfolio Values Become Concentrated over Time?
Why Should Claims Not Be Read on the Prior Art?
Impact of Post-Grant Proceedings
Consequences of Disclosing Confidential Information
Attorneys and Patent Profile Analytics
When is a House like a Patent?
Trademark Filing Considerations
Tools for Auditing a Patent Portfolio
"How Much" - Audit Action Sheet
Inventorship vs Ownership
Prior Art in Prosecution vs Prior Art in Litigation
Factors That Make a Patent Valuable
The Case of the Joint Marketing Agreement Gone Bad
Risks of Not Patenting
Assessing Executive Experience
By the Numbers Overview
Audit Action Sheet
Two Main Value Drivers
Why Do You Enjoy Being a Lawyer?
Joint Venture Ground Rules
How do Patent Prosecution Services Vary in Value?
Attributes of a Good Patent
Evaluation Agreement and Computer Codes
Segmenting a Portfolio
Seeking Money from Investors
Rebutting a Merely Descriptive Refusal
How Big Should My First Patent Be?
Prior Art and Rejections
What to Do When First Selecting a Mark
Calculating New Investments
A Less Expensive Alternative
Patent Strategy Considerations
Why Are Biologicals so Important?
Renewing a Trademark Registration
Infringing on Another Patent
Value-Driven Patent Portfolio
Improving Patent Portfolio Value
Patent Portfolio and Budgets/Spending
Demonstrating BioSimilarity Under U.S. Law
Important Attributes to Being a Successful Patent Lawyer
Goal of a Value-Driven Patent Portfolio
Schwegman, Lundberg & Woessner - Chemicals and Pharmaceuticals
Freedom to Operate (FTO) Process
What is an Invention?
Domain Registration Considerations
Is There Still a Place for Traditional Re-Examination?
FDA Guidelines for Demonstrating Biosimilarity
Engineers Not Understanding Patents
Repeating Competitor Audits
Freedom to Operate
Steps to Obtaining a Patent
Inter Partes Review
First Step in Performing a Patent Portfolio Audit
Scope Concepts and Headnotes
High Risk Joint Ventures
"Who" - Audit Action Sheet
Implementing a Value-Driven Portfolio Process
Date of First Use
PTAB Final Argument Trial Dynamics
Challenges When Dealing with Patent Matters
What Does an Audit Action Sheet Look Like?
What is Prior Art?
Freedom To Operate
How Long Does an FTO Take?
Patents and Practicing an Invention
Patent Ownership and Patent Profile Analytics
What is a BioSimilar?
Interpretational Differences Between Prosecution and Litigation
Moderate Risk Joint Ventures
Confidential Information and Business Damage
Signing an NDA
Claim Maps and BioSimilars
Impact of PTAB
Unlicensed Source Codes
Cost/Value Curve of Patent a Portfolio
Benefits of Audit Action Sheet
Merely Descriptive Refusal
Joint Venture and Financial Agreements
How is Open Source Software Enforced?
Independent Claim vs Dependent Claim
Value Management and Cash Flow
A Better Way to Allocate Patent Application Budgets
Open Source Initiative
Patent Trial and Appeal Board
Patent Profile Analytics and Managers
Categories of Marks
Get Your Assignments Straight - Contribution of Owners
Am I Required to Search for Prior Art?
Portfolio Dashboard - Inventor Information
How Does the Knowledge Gap Worsen Over Time?
How is the Entire Patent Considered Prior Art?
Discovering Annuity Information
Geographic Insight and Patent Profile Analytics
Attorneys Not Understanding the Market
Practicing an Invention
OSS Licensing Conditions
Common Reasons Trademarks Are Rejected
Intent of Patent Laws
Picking a Trademark
How is Open Source Incorporated into Software?
Freedom To Operate vs Clearance
How can OSS Negatively Affect a Company?
Becoming a Patent Lawyer
4 Ways to Prepare your Patent Portfolio for Battle.
Risks of OSS
Infringement on the Rights of Other Patents
Budgeting for Drafting and Prosecution
"Wheres" - Audit Action Sheet
Biologics Price Competition and Innovation Act
Impact of US Hatch Waxman Act 1984
Broad Patent Claim
Biologics vs Small Molecules
Is A United States Registered Trademark Effective in Other Countries?
What Should a Company Understand at the End of an IP Audit?
Importance of Getting a Patent
Importance of Freedom To Operate
Why Perform Risk Profile?
Limiting Issues Defined in District Court
Joint Venture Pitfalls
How Does the Knowledge Gap Develop?
The Advantage of Filing First
Post-Grant Proceedings and Patent Enforcement
What Engineers Can Learn from Patent Profile Analytics
Marking a Product
"Claims" of a Patent
How Should IP be Considered for Growth?
Requirements to Receive a Patent
IP Registration Density
What IP Should I Spend Money on First?